First Annual Joklik Distinguished Lectureship
Durham, N.C. —The Department of Molecular Genetics and Microbiology will host the First Annual Joklik Distinguished Lecture on September 24, 2010 in conjunction with the annual MGM departmental retreat on September 25. This year’s speaker is Bernard Moss, MD, PhD, Chief of the Laboratory of Viral Diseases, at the National Institute of Allergy and Infectious Diseases.
|Bernard Moss, MD, PhD
Chief of the Laboratory of Viral Diseases
National Institute of Allergy and Infectious Diseases
Bldg. 4, Rm. 229
4 Center Drive
Bethesda, MD 20892-0445
Seminar: Poxviruses do it all in the cytoplasm4:00pm-5:00pm
103 Bryan Research Building
Reception to follow lecture
Dr. Moss is a world renowned virologist whose work has been crucial to understanding how viruses infect cells and developing vaccines against viral diseases. His research, which has primarily focused on the mechanisms of virus replication in poxviruses such as the vaccinia virus, provides an extraordinary model system for both viruses and cell biology. His studies have illuminated processes of mRNA capping, transcriptional control of gene expression, virus morphogenesis, viral entry into cells, viral interactions with host immune functions, viral genome structure, and viral DNA replication. His research has translated to the development of powerful mammalian expression vectors and live virus vaccine vectors. In addition to his work on poxviruses, he has made major contributions to the understanding of HIV biology and immune responses against HIV. Through his groundbreaking work in both of these fields, he continues to promote the development of vaccines against HIV.
Dr. Moss has received numerous awards and prizes, including the Dickson Prize for Medical Research, the Invitrogen Eukaryotic Expression Award, the ICN International Prize in Virology, the Taylor International Prize in Medicine, and the Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research. He was elected to the National Academy of Sciences, American Academy of Microbiology, Fellow of the AAAS, and president of the American Society for Virology.
Dr. Moss is currently an editor of Virology and a member of the editorial boards of Journal of Virology, AIDS Research and Human Retroviruses, Current Opinion in Biotechnology, Advances in Virus Research, and the NIH Catalyst. He is an adjunct professor at George Washington University and the University of Maryland.
The Joklik Distinguished Lectureship honors and commemorates the myriad contributions of Dr. Bill (Wolfgang Karl) Joklik to the Department of Microbiology and Immunology at Duke, which he chaired; to the institution, specifically for his role as the co-founder of the Duke Comprehensive Cancer Center; and to the broader microbiology community for his research program in virology, service in founding the American Society for Virology, and for his editorial work for the journal Virology and the seminal text, Zinsser’s Microbiology.
Together with the Nobel Laureate Paul Berg, Dr. Joklik was responsible for the discovery of the enzyme terminal transferase. Dr. Joklik was the first to examine the mechanism of action of interferon–the first cytokine to be recognized in molecular terms in 1964–and was recently conferred an honorary member of the International Society for Interferon and Cytokine Research. Much of his scientific career was devoted to the development and application of molecular virology with a focus on reovirus and vaccinia. Many alumni who trained in his laboratory are leading investigators in biomedical research, including Joseph Nevins, PhD, who is the Barbara Levine University Professor of Breast Cancer Genomics.
Dr. Joklik is currently a James B. Duke Professor Emeritus of Molecular Genetics and Microbiology, a member of the National Academy of Sciences, and an active member of the community.